It is imperative that significant ocular surface disease and dry eye findings are treated prior to cataract surgery. If not properly addressed, patients may be at risk for less than desirable surgical results or a significant increase in dry eye symptoms following surgery.
This can occur as ocular surface disease can negatively impact the measurements and calculations your surgeon acquires to determine the power and prescription of your implant. Additionally, the surgical process can further disrupt and damage an already abnormal ocular surface resulting in significant flare-ups following surgery. Most concerning, however, is the increased risk of infections which can result from a higher bacterial load often present with ocular surface disease.